atropine: is used for

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.66
, alkaloid
Weight: 0.59
, agent
Weight: 0.57
, substance
Weight: 0.55
, medicine
Weight: 0.51
Siblings phenobarbital
Weight: 0.36
, acetaminophen
Weight: 0.36
, ibuprofen
Weight: 0.35
, morphine
Weight: 0.35
, metronidazole
Weight: 0.35

Related properties

Property Similarity
is used for 1.00
be used in rsi 0.95
be used with diphenoxylate 0.92

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.36
Similarity weight: 1.00
Evidence: 0.76
¬ Remarkable(atropine, is used for)
Evidence: 0.83
¬ Remarkable(metronidazole, is used for)

Remarkability from sibling implausibility

0.58
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.57
Plausible(atropine, is used for)
Evidence: 0.83
Remarkable(metronidazole, is used for)
Evidence: 0.59
¬ Plausible(metronidazole, is used for)

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.69
Similarity weight: 1.00
Evidence: 0.57
Plausible(atropine, is used for)
Evidence: 0.72
¬ Salient(atropine, is used for)

Similarity expansion

0.68
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.95
Evidence: 0.72
Salient(atropine, is used for)
Evidence: 0.59
¬ Salient(atropine, be used in rsi)
0.68
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.95
Evidence: 0.54
Typical(atropine, is used for)
Evidence: 0.36
¬ Typical(atropine, be used in rsi)
0.67
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.92
Evidence: 0.76
Remarkable(atropine, is used for)
Evidence: 0.60
¬ Remarkable(atropine, be used with diphenoxylate)
0.66
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.92
Evidence: 0.72
Salient(atropine, is used for)
Evidence: 0.56
¬ Salient(atropine, be used with diphenoxylate)
0.66
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.95
Evidence: 0.57
Plausible(atropine, is used for)
Evidence: 0.43
¬ Plausible(atropine, be used in rsi)
0.66
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.95
Evidence: 0.76
Remarkable(atropine, is used for)
Evidence: 0.79
¬ Remarkable(atropine, be used in rsi)
0.62
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.92
Evidence: 0.57
Plausible(atropine, is used for)
Evidence: 0.50
¬ Plausible(atropine, be used with diphenoxylate)
0.59
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.92
Evidence: 0.54
Typical(atropine, is used for)
Evidence: 0.53
¬ Typical(atropine, be used with diphenoxylate)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.89
Similarity weight: 1.00
Evidence: 0.72
Salient(atropine, is used for)
Evidence: 0.54
¬ Typical(atropine, is used for)
Evidence: 0.76
¬ Remarkable(atropine, is used for)

Typical implies Plausible

0.37
Rule weight: 0.48
Evidence weight: 0.77
Similarity weight: 1.00
Evidence: 0.57
Plausible(atropine, is used for)
Evidence: 0.54
¬ Typical(atropine, is used for)

Typicality and Rermarkability incompatibility between siblings

0.08
Rule weight: 0.14
Evidence weight: 0.61
Similarity weight: 1.00
Evidence: 0.76
¬ Remarkable(atropine, is used for)
Evidence: 0.51
¬ Typical(metronidazole, is used for)